Combination of Osimertinib and Pembrolizumab Successfully Overcome Dual Resistances in a Patient with Advanced Adenocarcinoma of the Lung, a Case Report
Keyword(s):
2009 ◽
Vol 109
(4)
◽
pp. 519-522
◽
2011 ◽
Vol 43
(S1)
◽
pp. 125-127
◽
1985 ◽
Vol 75
(10)
◽
pp. 547-550
◽
Keyword(s):